ArticleJTO clinical and research reports2024

A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC.

Vanita Noronha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.